期刊文献+

肝细胞癌中血管内皮生长因子及其受体的表达与意义 被引量:1

Expressions and significance of VEGF and VEGF receptors in hepatocellular carcinoma
下载PDF
导出
摘要 目的 :探讨血管内皮生长因子(VEGF)和血管内皮生长因子受体 (VEGFRs)在肝细胞癌 (HCC)肿瘤血管生成中的调节作用。方法 :采用免疫组化法检测 3 9例 (男 3 4例 ,女 5例 )共 41个经手术病理证实的HCC病灶VEGF、Flt 1和KDR/Flk 1的蛋白表达。观察病灶肿瘤大小、包膜、子灶、门静脉癌栓、肝门淋巴结转移和肝硬化等。记录HCC患者的临床资料 ,如年龄、HBsAg、HBV和AFP情况。手术结果记录病灶大小、数目、肝硬化和包膜情况。病理结果记录病理分级、肝硬化等情况。结果 :在转移高危组、包膜欠完整和 (或 )无包膜组、小肝癌组中VEGF表达阳性率均高于转移低危组、包膜完整组和大肝癌组 ,差异有统计学意义 ,P <0 0 5。而VEGF的表达与Ed mondson分级、HBV、HBsAg、AFP水平以及肝硬化之间差异均无统计学意义 ,P >0 0 5。KDR/Flk 1表达阳性病灶 2 9个 ,阳性率为 70 73 %( 2 9/4 1) ;KDR/Flk 1在转移高危组、包膜欠完整和 (或 )无包膜组、小肝癌组中表达的阳性率也均高于转移低危组、包膜完整组和大肝癌组 ,差异有统计学意义 ,P <0 0 5。KDR/Flk 1蛋白的表达亦与Edmondson分级、HBV、HBsAg、AFP水平、肝硬化之间差异无统计学意义 ,P >0 0 5。Flt 1阳性病灶 2 8个 ,阳性率为 68 2 9% ( 2 8/4 1) ;Flt OBJECTIVE:To study the expression and modulation of vascular endothelial growth factor (VEGF) and VEGF receptors (VEGFRs) in the angiogenesis of hepatocellular carcinoma (HCC). METHODS:Thirty nine cases (41 lesions) of HCC were proved surgically. The clinicopathological characteristics including the size, capsule, the edge of lesions, intrahepatic daughter foci, tumor-emboli in portal veins, lymphaden metastasis and hepatic cirrhosis were analysed. The details about the size, capsule and the edge of lesions were recorded after resection. The grades of differentiation and hepatic cirrhosis were recorded in pathology. The expressions of VEGF and VEGFRs were detected with immunohistochemical SP method. The clinical and histopathological characteristics of HCC were compared with the immunohistochemical results of VEGF, Flt-1 and KDR/Flk-1. RESULTS: The diameter was equal to or smaller than 5 cm in 22 lesions (22/41, 53.66%), the diameter was larger than 5 cm in 19 lesions (19/41, 46.34%); pseudocapsula were found in 12 lesions (12/41, 29.27%), incomplete pseudocapsula or non-pseudocapsula were found in 29 lesions (29/41, 70.73%). There were 11 lesions (11/41, 26.83%) in high potential invasion and metastasis (intrahepatic daughter foci, tumor-emboli in portal veins, lymphaden metastasis), 30 lesions (30/41, 73.17%) in the low potential invasion and metastasis group. Thirty-two lesions (32/41, 78.05%) were accompanied by hepatic cirrhosis and the others (9/41, 21.95%) were not. There were significantly high expressions of VEGF and KDR/Flk-1 in the group of high potential invasion and metastasis, in the group of HCC with incomplete pseudocapsula or without pseudocapsula, and in the group of lesions whose diameter equal to or smaller than 5 cm. The expressions of Flt-1 had no significance in all the groups mentioned above. It showed that VEGF expression correlated with KDR/Flk-1, but KDR/Flk-1 expressions did not correlate with Flt-1.CONCLUSIONS:VEGF and KDR/Flk-1 play a potentially important role in the angiogenesis, growth and metastasis of HCC.
出处 《肿瘤防治杂志》 2004年第12期1254-1257,共4页 China Journal of Cancer Prevention and Treatment
基金 山东省科技厅资助课题 ( 1998BB1CCA1)
关键词 肝肿瘤/代谢 肝细胞 病理学 内皮生长固子 受体 细胞表面 liver neoplasms/metabolism carcinoma,hepatocellular/pathology endothelial growth factors receptors,cell surface
  • 相关文献

参考文献12

  • 1Edmondson H A,Steiner P P Primary carcinoma oftheliver:a study of 100 cases among 48,900 necropsies[J]. Cancer, 1954,7(7) :462-503.
  • 2Folkman J. Tumor angiogenesis; therapeutic implication[J]. N EnglJ Med, 1971, 285(21): 1182-1186.
  • 3Teo N B, Shoker B S, Matin L, et al. Angiogenesis in pre-invasive cancers[J]. Anticancer Res, 2002, 22(4) :2061-2072.
  • 4Seo Y, Baba H, Fukuda T, et al. High expression of vascular endothielial growth factor is associated with liver metastasis and a poor prognosis for patients with ductal pancreatic adenocarcinoma[J]. Cancer, 2000, 88(10): 2239-2245.
  • 5高志芹,燕霞.肝细胞肝癌肿瘤血管生成及其临床病理意义[J].临床与实验病理学杂志,2003,19(4):401-404. 被引量:9
  • 6Li X M, Tang Z Y, Zhou G, et al. Significance of vascular endothelial growth factor mRNA expression in invasion and metastasis of hepatocelluar carcinoma[J]. J Exp Clin Cancer Res, 1998,17(1): 13-17.
  • 7Park Y N, Kim Y B, Yang K M, et al. Increased expression of vascular endothelial growth factor and angiogenesis in the early stage of multistep hepatocarcinogenesis[J]. Arch Pathol Lab Med, 2000, 124(7): 1061-1065.
  • 8Shimamura T, Saito S, Morita K, et al. Detection of vascular endothelial growth factor and its receptor expression in human hepatocellular carcinoma biopsy specimens[J]. J GastroenterolHepatol, 2000, 15(6): 640-646.
  • 9von Marschall Z, Cramer T, Hocker M, et al. Dual mechanism of vascular endothelial growth factor upregulation by hypoxia in human hepatocellular carcinoma[J]. Gut, 2001, 48(1):87 96.
  • 10Poon R T, Ng I O, Lau C, et al. Serum vascular endothelial growth factor predicts invasion hepatocellular carcinoma: a prospective study[J]. Ann Surg, 2001, 233(2): 227-235.

二级参考文献16

  • 1[1]Tanigawa N, Lu C, Mitsui T, et al. Quantitation of sinu-soid-like vessels in hepatocellular carcinoma: its clinical and prognostic significance. Hepatology, 1997,26(5): 121 ~623.
  • 2[2]Folkman J. Tumor angiogenesis; therapeutic implication. N Engl J Med, 1971,285(21) :1182~6.
  • 3[3]Fox SB, Leek RD, Weekes MP, et al. Quantitation and prognostic value of breast cancer angiogenesis: comparison of microvessel density, Chalkley count, and computer image analysis. J Pathol,1995,177(3) :275~83.
  • 4[4]Giatromanolaki A, Koukourakis M, OByrne K, et al. Prognostic value of angiogenesis in operable non-small cell lung cancer. J Pathol, 1996,179(1) :80~8.
  • 5[5]Weidner N, Carroll PR, Flax J, et al. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol,1993,143(2) :401~9.
  • 6[6]Brustmann H, Riss P, Naude S. The relevance of angiogenesis in benign and malignant epithelial tumors of the ovary: a quantitative histological study. Gynecol Oncol, 1997,67 ( 1 ): 20 ~ 6.
  • 7[7]El-Assal ON, Yamanoi A, Soda Y, et al. Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver. Hepatology, 1998,27(6): 1554~62.
  • 8[8]Ker CG, Chen HY, Juan CC, et al. Role of angiogenesis in hepatitis and hepatocellular carcinoma. Hepatogastroenterology,1999,46(26) :646~50.
  • 9[9]Sun HC, Tang ZY, Li XM, et al. Microvessel density of hepatocellular carcinoma: its relationship with prognosis. J Cancer Res Clin Oncol, 1999,125(7) :419~26.
  • 10[10]Senger DR, Van de Water L, Brown LF, et al. Vascular permeability factor (VPF, VEGF) in tumor biology. Cancer Metastasis Rev, 1993,12(3~4) :303~24.

共引文献8

同被引文献8

  • 1袁五营,李遂莹,李建军,高夏,王济森,聂志鸿,李大军,乔保安.血管内皮生长因子在非小细胞肺癌组织中的表达及其临床意义[J].中国现代医学杂志,2005,15(24):3743-3745. 被引量:3
  • 2贺军,李汉贤,刘辉.乳腺癌患者血清血管内皮生长因子的表达及临床意义[J].中国现代医学杂志,2006,16(6):847-850. 被引量:7
  • 3Eilashir SM, Harborth J, Lendeckel W,et al. Dupleses of 21 nucleotiode RNAs mediate RNA interference in cultured mammalian cells[J]. Nature. 2004,411(6846) :494-498.
  • 4Zamore PD, Tuschl T, Sharp PA, et al. RNAi: double stranded RNA directs the ATP dependent cleavage of mRNA at 21 to 23 nucleotide intervals[J]. Cell,2000,101(1):25-33.
  • 5Bergers G,Song S, Meyer- Morse NM, et al. Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors[J]. J Clin Investig,2003,111:1287-1295.
  • 6Ferrara N, Henzal WJ. Pituitary follicular cells secrete a novel heparin-binding growth factor specifie for vascularendothelial cell[J]. Biochem Biophys Res Commun, 1989,161:851-858.
  • 7Ferrara N. The role of vascular endothelial growth factor in pathological angiogenesis[J].Breast Cancer Res Treat, 1995,36 ( 2 ) : 127-137.
  • 8赵林,韩彪,刘健,蒋鹏,马敏杰.血管内皮生长因子在食管癌中的表达及其意义[J].中国现代医学杂志,2004,14(2):59-61. 被引量:7

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部